| |
制药公司、企业
-
Abbott
Laboratories Discovering, developing and
marketing innovative health care solutions across the spectrum of
health care.
-
Actinova
Developing innovative new vaccines and antibacterial therapies.
-
Adolar
Committed to the development of novel analgesics and pain-related
therapeutics based upon recent advances in proprietary medicinal chemistry
and recombinant opioid receptor technology.
-
Agouron
Pharmaceuticals Applying protein structure-based drug design to
the discovery of new therapeutic drugs for treatment of cancer, AIDS
and other serious diseases.
-
-
-
Alliance
Pharmaceutical Focusing on the application of scientific discoveries
that can be developed into innovative drug products.
-
-
American
Home Products Vaccines, prescription drugs, biotechnology, agricultural
and animal healthcare products.
-
-
-
Angiotech
Pharmaceuticals Development of medical device coatings and treatments
for chronic inflammatory diseases through reformulation of the anticancer
drug, paclitaxel.
-
Antisoma
Aiming to develop tumour targeted products that provide safer and
more effective methods of diagnosing and treating cancer.
-
Apoptogen
An early stage biotechnology company in apoptosis research for the
discovery of novel therapeutics for certain human diseases. Focus
is on optimizing drug discovery and gene therapy applications in neurodegenerative
diseases and cancer.
-
Ariad
Pharmaceuticals Discovery and development of proprietary platform
technologies and small-molecule therapeutic products based on gene
regulation and signal transduction.
-
-
-
-
Avigen
Development of gene therapy products derived from adeno-associated
virus ("AAV") for the treatment of inherited and acquired
diseases.
-
-
Axys
Pharmaceuticals Created through the merger of Arris Pharmaceutical
and Sequanna Therapeutics in January 1998.
- Bayer
Home Page
- Baxter
- Berlex
Betaseron?Multiple Sclerosis Resource Center
- Bio Balance
A Biotechnology/Pharmaceutical Discovery Company.
- Biogen,
Inc. Biotechnology company principally engaged in developing genetically
engineered human pharmaceuticals.
- Biophage
Discovery, development and commercialization of novel, unique and
useful biological products for the rapid diagnosis and targeted treatment
of bacterial infections and cancer.
- Biopure
A privately held biopharmaceutical company that develops, manufactures
and markets oxygen-carrying hemoglobin solutions, or "oxygen
therapeutics," for use in veterinary and human medicine.
- Biovail A full-service
pharmaceutical company that applies its proprietary drug delivery
technologies in developing "oral controlled-release" products.
- Boehringer
Ingelheim
- Boehringer
Mannheim Biochemicals As of March 1998, Roche Molecular Biochemicals.
- Bristol-Myers
Squibb Medicines, nutritionals and medical devices, worldwide.
- DepoTech
A drug delivery company dedicated to the development and manufacture
of sustained-release therapeutic products based on DepoFoam
technology.
- Dermik
Laboratories
- Destiny
Pharmaceuticals Conducts proprietary and contract research within
the pharmaceutical R&D business sector. Destiny's mission is to
identify and develop patented therapeutic pharmaceutical technologies
for exploitation by the pharmaceutical industry.
- diaDexus Discovery
and validation of novel genomic biomarkers for the detection and treatment
of disease.
- Draxis
Health Veterinary pharmaceuticals and DRAXIMAGE, engaged
in the research, development, manufacture, marketing
and sale of radiopharmaceuticals for diagnostic and therapeutic purposes.
- Dura
Pharmaceuticals Developer and marketer of prescription pharmaceutical
products for the treatment of allergies, asthma and related respiratory
conditions.
- Exelixis
Using model organism genetics and related technologies for the identification
and validation of high-quality screening targets,
therapeutic proteins and biopesticides for the pharmaceutical, human
diagnostic, crop protection and animal health industries.
- Gene-Cell
A biotechnology company dedicated to advancing human gene therapy
treatment of disease at the genetic (DNA) level.
- Gen-Probe
Developing, manufacturing, and commercializing diagnostic products
based on a patented DNA probe technology.
- Gene
Medicine, Inc.
- Genentech
- Genetics
Institute, Inc. Biotechnology firm developing protein-based therapeutics.
- Genetronics
A drug delivery company specializing in developing technology and
hardware which potentially will allow physicians more efficiently
and cost-effectively to deliver life-saving drugs or beneficial genes
to patients with catastrophic illnesses, including cancer and heart
disease. Expertise in electroporation.
- Genset
A fully integrated genomics company engaged in providing tailored
genomics information to the pharmaceutical industry through focused
strategic partnerships.
- Genzyme
A broad range of products and services to improve health care.
- Gilead
Sciences Focused on infectious diseases and oncology.
- Glaxo
Wellcome
- GLYCODesign
A private, biopharmaceutical company engaged in the discovery and
early stage clinical development of novel therapeutics for the treatment
of cancer, infectious diseases and inflammation.
- ImClone
Systems Development of novel treatments for cancer and cancer-related
disorders.
- ImmunoGen
Focused on Tumor-Activated Prodrugs for colorectal cancer, small-cell
lung cancer and other aggressive malignancies.
- Immunoscience
- Immunex
- Impotence
information Pharmacia & Upjohn
- Intronn
Technology for gene therapy that exploits the differential gene expression
between normal and diseased cells.
- Medco
Research
- Medeva
Develops, manufactures and markets prescription pharmaceutical products.
Focused principally on Central Nervous System; Respiratory; Vaccines;
Hospital Products; Gastrointestinal; and Dermatology.
- Medicis
Pharmaceutical Corp.
- MediGene
Dedicated to the discovery, development and commercialization of novel
molecular therapies for the treatment of major, life-threatening diseases.
- Merck
KGaA European group in pharmaceuticals, laboratory business and
specialty chemicals.
- Merck
MSD ... Merck Sharp & Dohme
- Micrologix
Biotech Developing treatment options for life-threatening diseases
caused by multidrug-resistant bacteria.
- Mikhaus
Laboratories A clinical stage biopharmaceutical company focused
on therapeutics for chronic diseases.
- Monsanto
- Myriad
A biopharmaceutical company focused on the development of therapeutic
and diagnostic products using genomic and proteomic technologies.
- OGS
Oxford Glycosciences exploiting the protein targets emerging from
its proteomics programmes.
- Organon
The largest Dutch research-based pharmaceutical company and the largest
pharmaceutical business unit of Akzo Nobel.
- Otsuka
Pharmaceutical Co.
- Sandoz
- Searle
healthNet
- Selective
Genetics Commercialization of site-specific gene therapeutics
and DNA devices for tissue repair and regeneration.
- Signal
Pharmaceuticals An integrated target and drug discovery company
focused on identifying new classes of small molecule drugs that regulate
genes and the production of disease-causing proteins.
- SmithKline
Beecham
- SUGEN
Developing new drugs to target signal transduction pathways inside
the body's cells.
- SYNSORB
Carbohydrate based pharmaceuticals targetting GI indications that
currently have no therapy or inadequate treatments.

|
|